Molecular diagnosis of Rett syndrome

Journal of Child Neurology

Volumn 20, Issue 9, 2005, Pages 732-736

  Huppke, Peter ^a   Gärtner, Jutta ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

METHYL CPG BINDING PROTEIN 2;

ARTICLE; DIAGNOSTIC PROCEDURE; FEMALE; GENE MUTATION; HUMAN; MALE; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; RETT SYNDROME; SEX DIFFERENCE; X CHROMOSOME;

EID: 27144481208     PISSN: 08830738     EISSN: None     Source Type: Journal    
DOI: 10.1177/08830738050200090601     Document Type: Article

References (47)

1. Sirianni N, Naidu S, Pereira J, et al: Rett syndrome: Confirmation of X-linked dominant inheritance, and localization of the gene to Xq28. Am J Hum Genet 1998;63:1552-1558.
2. Amir RE, Van den Veyver IB, Wan M, et al: Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat Genet 1999;23:185-188.
3. Amir R, Dahle EJ, Toriolo D, et al: Candidate gene analysis in Rett syndrome and the identification of 21 SNPs in Xq. Am J Med Genet 2000;90:69-71.
4. Adler DA, Quaderi NA, Brown SD, et al: The X-linked methylated DNA binding protein, MECP2, is subject to X inactivation in the mouse. Mamm Genome 1995;6:491-492.
5. D'Esposito M, Quaderi NA, Ciccodicola A, et al: Isolation, physical mapping, and Northern analysis of the X-linked human gene encoding methyl CpG-binding protein, MECP2. Mamm Genome 1996;7:533-535.
6. Mnatzakanian GN, Lohi H, Munteanu I, et al: A previously unidentified MECP2 open reading frame defines a new protein isoform relevant to Rett syndrome. Nat Genet 2004;36:339-341.
7. Kriaucionis S, Bird A: The major form of MECP2 has a novel N-terminus generated by alternative splicing. Nucleic Acids Res 2004;32:1818-1823.
8. Lewis JD, Meehan RR, Henzel WJ, et al: Purification, sequence, and cellular localization of a novel chromosomal protein that binds to methylated DNA. Cell 1992;69:905-914.
9. Nan X, Meehan RR, Bird A: Dissection of the methyl-CpG binding domain from the chromosomal protein MECP2. Nucleic Acids Res 1993;21:4886-4892.
10. Nan X, Campoy FJ, Bird A: MECP2 is a transcriptional repressor with abundant binding sites in genomic chromatin. Cell 1997;88:471-481.
11. Chandler SP, Guschin D, Landsberger N, et al: The methyl-CpG binding transcriptional repressor MECP2 stably associates with nucleosomal DNA. Biochemistry 1999;38:7008-7018.
12. Evans JC, Archer HL, Whatley SD, et al: Variation in exon 1 coding region and promoter of MECP2 in Rett syndrome and controls. Eur J Hum Genet 2005;13:124-126.
13. Shibayama A, Cook EH Jr, Feng J, et al: MECP2 structural and 3́-UTR variants in schizophrenia, autism and other psychiatric diseases: A possible association with autism. Am J Med Genet 2004;128B:50-53.
14. Beyer KS, Blast F, Bacchelli E, et al: Mutation analysis of the coding sequence of the MECP2 gene in infantile autism. Hum Genet 2002;111:305-309.
15. Buyse IM, Fang P, Hoon KT, et al: Diagnostic testing for Rett syndrome by DHPLC and direct sequencing analysis of the MECP2 gene: Identification of several novel mutations and polymorphisms. Am J Hum Genet 2000;67:1428-1436.
16. Thistlethwaite WA, Moses LM, Hoffbuhr KC, et al: Rapid genotyping of common MECP2 mutations with an electronic DNA microchip using serial differential hybridization. J Mol Diagn 2003;5:121-126.
17. Erlandson A, Samuelsson L, Hagberg B, et al: Multiplex ligation-dependent probe amplification (MLPA) detects large deletions in the MECP2 gene of Swedish Rett syndrome patients. Genet Test 2003;7:329-332.
18. Laccone F, Junemann I, Whatley S, et al: Large deletions of the MECP2 gene detected by gene dosage analysis in patients with Rett syndrome. Hum Mutat 2004;23:234-244.
19. Bourdon V, Philippe C, Grandemenge A, et al: Deletion screening by fluorescence in situ hybridization in Rett syndrome patients. Ann Genet 2001;44:191-194.
20. Ariani F, Mari F, Pescucci C, et al: Real-time quantitative PCR as a routine method for screening large rearrangements in Rett syndrome: Report of one case of MECP2 deletion and one case of MECP2 duplication. Hum Mutat 2004;24:172-177.
21. Miltenberger-Miltenyi G, Laccone F: Mutations and polymorphisms in the human methyl CpG-binding protein MECP2. Hum Mutat 2003;22:107-115.
22. Lee SS, Wan M, Francke U: Spectrum of MECP2 mutations in Rett syndrome. Brain Dev 2001;23(Suppl 1):S138-S143.
23. Yusufzai TM, Wolffe AP: Functional consequences of Rett syndrome mutations on human MECP2. Nucleic Acids Res 2000;28:4172-4179.
24. Huppke P, Held M, Laccone F, et al: The spectrum of phenotypes in females with Rett syndrome. Brain Dev 2003;25:346-351.
25. Oexle K, Thamm-Mucke B, Mayer T, et al: Macrocephalic mental retardation associated with a novel C-terminal MECP2 frameshift deletion. Eur J Pediatr 2004.
26. Lobo-Menendez F, Sossey-Alaoui K, Bell JM, et al: Absence of MECP2 mutations in patients from the South Carolina Autism Project. Am J Med Genet B Neuropsychiatr Genet 2003;117:97-101.
27. Watson P, Black G, Ramsden S, et al: Angelman syndrome phenotype associated with mutations in MECP2, a gene encoding a methyl CpG binding protein. J Med Genet 2001;38:224-228.
28. Hitchins MP, Rickard S, Dhalla F, et al: Investigation of UBE3A and MECP2 in Angelman syndrome (AS) and patients with features of AS. Am J Med Genet A 2004;125:167-172.
29. Trappe R, Laccone F, Cobilanschi J, et al: MECP2 mutations in sporadic cases of Rett syndrome are almost exclusively of paternal origin. Am J Hum Genet 2001;68:1093-1101.
30. Hoffbuhr K, Devaney JM, LaFleur B, et al: MECP2 mutations in children with and without the phenotype of Rett syndrome. Neurology 2001;56:1486-1495.
31. Villard L, Kpebe A, Cardoso C, et al: Two affected boys in a Rett syndrome family: Clinical and molecular findings. Neurology 2000;55:1188-1193.
32. Wan M, Lee SS, Zhang X, et al: Rett syndrome and beyond: Recurrent spontaneous and familial MECP2 mutations at CpG hotspots. Am J Hum Genet 1999;65:1520-1529.
33. Zeev BB, Yaron Y, Schanen NC, et al: Rett syndrome: Clinical manifestations in males with MECP2 mutations. J Child Neurol 2002;17:20-24.
34. Lynch SA, Whatley SD, Ramesh V, et al: Sporadic case of fatal encephalopathy with neonatal onset associated with a T158M missense mutation in MECP2. Arch Dis Child Fetal Neonatal Ed 2003;88:F250-F252.
35. Leonard H, Silberstein J, Falk R, et al: Occurrence of Rett syndrome in boys. J Child Neurol 2001;16:333-338.
36. Clayton-Smith J, Watson P, Ramsden S, et al: Somatic mutation in MECP2 as a non-fatal neurodevelopmental disorder in males. Lancet 2000;356:830-832.
37. Schwartzman JS, Bernardino A, Nishimura A, et al: Rett syndrome in a boy with a 47,XXY karyotype confirmed by a rare mutation in the MECP2 gene. Neuropediatrics 2001;32:162-164.
38. Kleefstra T, Yntema HG, Nillesen WM, et al: MECP2 analysis in mentally retarded patients: Implications for routine DNA diagnostics. Eur J Hum Genet 2004;12:24-28.
39. Couvert P, Bienvenu T, Aquaviva C, et al: MECP2 is highly mutated in X-linked mental retardation. Hum Mol Genet 2001; 10:941-946.
40. Imessaoudene B, Bonnefont JP, Royer G, et al: MECP2 mutation in non-fatal, non-progressive encephalopathy in a male. J Med Genet 2001;38:171-174.
41. Klauck SM, Lindsay S, Beyer KS, et al: A mutation hot spot for non-specific X-linked mental retardation in the MECP2 gene causes the PPM-X syndrome. Am J Hum Genet 2002;70:1034-1037.
42. Orrico A, Lam C, Galli L, et al: MECP2 mutation in male patients with non-specific X-linked mental retardation. FEBS Lett 2000;481:285-288.
43. Winnepenninckx B, Errijgers V, Hayez-Delatte F, et al: Identification of a family with nonspecific mental retardation (MRX79) with the A140V mutation in the MECP2 gene: Is there a need for routine screening? Hum Mutat 2002;20:249-252.
44. Yntema HG, Oudakker AR, Kleefstra T, et al: In-frame deletion in MECP2 causes mild nonspecific mental retardation. Am J Med Genet 2002;107:81-83.
45. Gomot M, Gendrot C, Verloes A, et al: MECP2 gene mutations in non-syndromic X-linked mental retardation: Phenotype-genotype correlation. Am J Med Genet A 2003;123:129-139.
46. Moog U, Smeets EE, van Roozendaal KE, et al: Neurodevelopmental disorders in males related to the gene causing Rett syndrome in females (MECP2). Eur J Paediatr Neurol 2003; 7:5-12.
47. Huppke P, Kohler K, Laccone F, et al: Indication for genetic testing: A checklist for Rett syndrome. J Pediatr 2003; 142:332-335.